$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 ... 28 29 30 31 32 33 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.45 | 3,852 | 86,477 | 97,222 | 101.1 K to 97.2 K (-3.81 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.45 | 300 | 6,734 | 101,074 | 101.4 K to 101.1 K (-0.30 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.44 | 3,500 | 78,540 | 101,374 | 104.9 K to 101.4 K (-3.34 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.43 | 1,100 | 24,673 | 104,874 | 106 K to 104.9 K (-1.04 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.42 | 1,628 | 36,500 | 105,974 | 107.6 K to 106 K (-1.51 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.41 | 996 | 22,320 | 107,602 | 108.6 K to 107.6 K (-0.92 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.40 | 2,776 | 62,182 | 108,598 | 111.4 K to 108.6 K (-2.49 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.39 | 500 | 11,195 | 111,374 | 111.9 K to 111.4 K (-0.45 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.38 | 4,450 | 99,591 | 111,874 | 116.3 K to 111.9 K (-3.83 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.37 | 2,550 | 57,044 | 116,324 | 118.9 K to 116.3 K (-2.15 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.36 | 1,150 | 25,714 | 118,874 | 120 K to 118.9 K (-0.96 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.35 | 2,800 | 62,580 | 120,024 | 122.8 K to 120 K (-2.28 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 22.34 | 300 | 6,702 | 122,824 | 123.1 K to 122.8 K (-0.24 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Buy | M | 6.13 | 90,000 | 551,700 | 123,124 | 33.1 K to 123.1 K (+271.71 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | M | 7.16 | 10,000 | 71,600 | 320,000 | |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 22.40 | 10,000 | 224,000 | 4,895 | 14.9 K to 4.9 K (-67.14 %) |
Sep 18 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | M | 7.16 | 10,000 | 71,600 | 14,895 | 4.9 K to 14.9 K (+204.29 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 10,000 | 64,600 | 1,234,114 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 21.00 | 10,000 | 210,000 | 6,695 | 16.7 K to 6.7 K (-59.90 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 10,000 | 64,600 | 16,695 | 6.7 K to 16.7 K (+149.37 %) |
Aug 16 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 6.13 | 4,000 | 24,520 | 236,000 | |
Aug 16 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Sell | S | 20.26 | 4,000 | 81,040 | 2,607 | 6.6 K to 2.6 K (-60.54 %) |
Aug 16 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Buy | M | 6.13 | 4,000 | 24,520 | 6,607 | 2.6 K to 6.6 K (+153.43 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | M | 7.72 | 30,000 | 231,600 | 45,000 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.25 | 400 | 8,100 | 10,000 | 10.4 K to 10 K (-3.85 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.00 | 8,300 | 166,000 | 10,400 | 18.7 K to 10.4 K (-44.39 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.01 | 200 | 4,002 | 18,700 | 18.9 K to 18.7 K (-1.06 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.03 | 200 | 4,006 | 18,900 | 19.1 K to 18.9 K (-1.05 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.07 | 1,600 | 32,112 | 19,100 | 20.7 K to 19.1 K (-7.73 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.08 | 200 | 4,016 | 20,700 | 20.9 K to 20.7 K (-0.96 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.09 | 1,000 | 20,090 | 20,900 | 21.9 K to 20.9 K (-4.57 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.11 | 200 | 4,022 | 21,900 | 22.1 K to 21.9 K (-0.90 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.12 | 200 | 4,024 | 22,100 | 22.3 K to 22.1 K (-0.90 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.13 | 1,600 | 32,208 | 22,300 | 23.9 K to 22.3 K (-6.69 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.14 | 800 | 16,112 | 23,900 | 24.7 K to 23.9 K (-3.24 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.15 | 600 | 12,090 | 24,700 | 25.3 K to 24.7 K (-2.37 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.16 | 1,000 | 20,160 | 25,300 | 26.3 K to 25.3 K (-3.80 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.17 | 600 | 12,102 | 26,300 | 26.9 K to 26.3 K (-2.23 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.18 | 1,500 | 30,270 | 26,900 | 28.4 K to 26.9 K (-5.28 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.19 | 1,100 | 22,209 | 28,400 | 29.5 K to 28.4 K (-3.73 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.21 | 300 | 6,063 | 29,500 | 29.8 K to 29.5 K (-1.01 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.23 | 100 | 2,023 | 29,800 | 29.9 K to 29.8 K (-0.33 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Sell | S | 20.24 | 100 | 2,024 | 29,900 | 30 K to 29.9 K (-0.33 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Buy | M | 7.72 | 30,000 | 231,600 | 30,000 | 0 to 30 K |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | M | 7.16 | 20,000 | 143,200 | 330,000 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.21 | 7,500 | 151,575 | 4,895 | 12.4 K to 4.9 K (-60.51 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.37 | 100 | 2,037 | 12,395 | 12.5 K to 12.4 K (-0.80 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.36 | 700 | 14,252 | 12,495 | 13.2 K to 12.5 K (-5.31 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.35 | 1,000 | 20,350 | 13,195 | 14.2 K to 13.2 K (-7.04 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.34 | 1,600 | 32,544 | 14,195 | 15.8 K to 14.2 K (-10.13 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.33 | 3,400 | 69,122 | 15,795 | 19.2 K to 15.8 K (-17.71 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.32 | 100 | 2,032 | 19,195 | 19.3 K to 19.2 K (-0.52 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.31 | 300 | 6,093 | 19,295 | 19.6 K to 19.3 K (-1.53 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.30 | 800 | 16,240 | 19,595 | 20.4 K to 19.6 K (-3.92 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.29 | 200 | 4,058 | 20,395 | 20.6 K to 20.4 K (-0.97 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.28 | 1,100 | 22,308 | 20,595 | 21.7 K to 20.6 K (-5.07 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.26 | 100 | 2,026 | 21,695 | 21.8 K to 21.7 K (-0.46 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.25 | 2,100 | 42,525 | 21,795 | 23.9 K to 21.8 K (-8.79 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.23 | 700 | 14,161 | 23,895 | 24.6 K to 23.9 K (-2.85 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Sell | S | 20.22 | 300 | 6,066 | 24,595 | 24.9 K to 24.6 K (-1.21 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Buy | M | 7.16 | 20,000 | 143,200 | 24,895 | 4.9 K to 24.9 K (+408.58 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 11.74 | 1,049 | 12,315 | 107,804 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.13 | 531 | 3,255 | 108,853 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.37 | 1,053 | 6,708 | 109,384 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 21.08 | 2,633 | 55,504 | 0 | 2.6 K to 0 (-100.00 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.13 | 531 | 3,255 | 2,633 | 2.1 K to 2.6 K (+25.26 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.37 | 1,053 | 6,708 | 2,101 | 1 K to 2.1 K (+100.48 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 11.74 | 1,049 | 12,315 | 1,049 | 0 to 1 K |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 35,886 | 231,824 | 1,244,114 | |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 20.21 | 2,000 | 40,420 | 6,695 | 8.7 K to 6.7 K (-23.00 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 20.20 | 33,886 | 684,497 | 8,695 | 42.6 K to 8.7 K (-79.58 %) |
Aug 14 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 6.46 | 35,886 | 231,824 | 42,581 | 6.7 K to 42.6 K (+536.01 %) |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,500 | 101,250 | 278,000 | |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 21.00 | 12,500 | 262,500 | 0 | 12.5 K to 0 (-100.00 %) |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,500 | 101,250 | 12,500 | 0 to 12.5 K |
Aug 06 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.05 | 300 | 5,415 | 6,695 | 7 K to 6.7 K (-4.29 %) |
Aug 06 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.04 | 600 | 10,824 | 6,995 | 7.6 K to 7 K (-7.90 %) |
Aug 06 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.00 | 100 | 1,800 | 7,595 | 7.7 K to 7.6 K (-1.30 %) |
Aug 06 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.01 | 600 | 10,806 | 7,695 | 8.3 K to 7.7 K (-7.23 %) |
Aug 06 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.02 | 400 | 7,208 | 8,295 | 8.7 K to 8.3 K (-4.60 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | M | 4.00 | 12,500 | 50,000 | 442,733 | |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.27 | 1,150 | 21,012 | 10,000 | 11.2 K to 10 K (-10.31 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.27 | 100 | 1,827 | 11,150 | 11.3 K to 11.2 K (-0.89 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.26 | 1,150 | 21,000 | 11,250 | 12.4 K to 11.3 K (-9.27 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.26 | 100 | 1,826 | 12,400 | 12.5 K to 12.4 K (-0.80 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.21 | 400 | 7,284 | 12,500 | 12.9 K to 12.5 K (-3.10 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.20 | 450 | 8,190 | 12,900 | 13.4 K to 12.9 K (-3.37 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.20 | 400 | 7,280 | 13,350 | 13.8 K to 13.4 K (-2.91 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.19 | 200 | 3,638 | 13,750 | 14 K to 13.8 K (-1.43 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.18 | 450 | 8,181 | 13,950 | 14.4 K to 14 K (-3.12 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.18 | 1,100 | 19,998 | 14,400 | 15.5 K to 14.4 K (-7.10 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.16 | 200 | 3,632 | 15,500 | 15.7 K to 15.5 K (-1.27 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.15 | 300 | 5,445 | 15,700 | 16 K to 15.7 K (-1.87 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.09 | 1,250 | 22,613 | 16,000 | 17.3 K to 16 K (-7.25 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.17 | 900 | 16,353 | 17,250 | 18.2 K to 17.3 K (-4.96 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.16 | 1,750 | 31,782 | 18,150 | 19.9 K to 18.2 K (-8.79 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.15 | 600 | 10,890 | 19,900 | 20.5 K to 19.9 K (-2.93 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.14 | 300 | 5,442 | 20,500 | 20.8 K to 20.5 K (-1.44 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.13 | 450 | 8,159 | 20,800 | 21.3 K to 20.8 K (-2.12 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.12 | 1,150 | 20,839 | 21,250 | 22.4 K to 21.3 K (-5.13 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Sell | S | 18.12 | 100 | 1,812 | 22,400 | 22.5 K to 22.4 K (-0.44 %) |
Jul 03 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Buy | M | 4.00 | 12,500 | 50,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Jul 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.21 | 500 | 9,106 | 8,695 | 9.2 K to 8.7 K (-5.44 %) |
Jul 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.33 | 500 | 9,166 | 9,195 | 9.7 K to 9.2 K (-5.16 %) |
Jul 09 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.31 | 1,000 | 18,310 | 9,695 | 10.7 K to 9.7 K (-9.35 %) |
Jun 27 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 17.65 | 2,500 | 44,125 | 10,695 | 13.2 K to 10.7 K (-18.95 %) |
Jun 21 2007 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | A | 17.33 | 30,000 | 519,900 | 30,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Option Exercise | A | 17.33 | 60,000 | 1,039,800 | 718,243 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | ASELAGE STEVE | SVP, Global Commerc ... | Option Exercise | A | 17.33 | 70,000 | 1,213,100 | 350,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 17.33 | 60,000 | 1,039,800 | 290,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | A | 17.33 | 30,000 | 519,900 | 110,437 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 11.74 | 520 | 6,105 | 80,437 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.13 | 11 | 67 | 80,957 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Option Exercise | M | 6.37 | 514 | 3,274 | 80,968 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Sell | S | 17.54 | 1,045 | 18,332 | 0 | 1 K to 0 (-100.00 %) |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 11.74 | 520 | 6,105 | 1,045 | 525 to 1 K (+99.05 %) |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.13 | 11 | 67 | 525 | 514 to 525 (+2.14 %) |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Wood Mark | VP, Human Resources | Buy | M | 6.37 | 514 | 3,274 | 514 | 0 to 514 |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | A | 17.33 | 45,000 | 779,850 | 240,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 17.33 | 160,000 | 2,772,800 | 1,280,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | Swiedler Stuart J | SVP, Clinical Affai ... | Option Exercise | A | 17.33 | 60,000 | 1,039,800 | 455,233 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Option Exercise | A | 17.33 | 70,000 | 1,213,100 | 754,127 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 0.00 | 1,250 | 0 | 1,250 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Option Exercise | A | 17.33 | 7,500 | 129,975 | 37,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 1,250 | 0 | 1,250 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | A | 17.33 | 7,500 | 129,975 | 67,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 3,750 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LAPALME PIERRE | Director | Option Exercise | A | 17.33 | 22,500 | 389,925 | 112,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | A | 17.33 | 15,000 | 259,950 | 135,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Option Exercise | A | 17.33 | 15,000 | 259,950 | 75,000 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jun 11 2007 | BMRN | BIOMARIN PHARMACEU ... | KLEIN JOSEPH III | Director | Option Exercise | A | 17.33 | 15,000 | 259,950 | 45,000 | |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 6.46 | 10,000 | 64,600 | 1,120,000 | |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.40 | 500 | 9,200 | 13,195 | 13.7 K to 13.2 K (-3.65 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.38 | 100 | 1,838 | 13,695 | 13.8 K to 13.7 K (-0.72 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.41 | 900 | 16,570 | 13,795 | 14.7 K to 13.8 K (-6.12 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.41 | 100 | 1,841 | 14,695 | 14.8 K to 14.7 K (-0.68 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.40 | 300 | 5,520 | 14,795 | 15.1 K to 14.8 K (-1.99 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.40 | 700 | 12,880 | 15,095 | 15.8 K to 15.1 K (-4.43 %) |
Jun 05 2007 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 18.39 | 200 | 3,678 | 15,795 | 16 K to 15.8 K (-1.25 %) |